Vivoryon Therapeutics

Drug development for the treatment of Alzheimer’s disease

Vivoryon Logo
About Vivoryon Therapeutics

Targeting diseases at their molecular root

Vivoryon Therapeutics is a biopharmaceutical company engaged in the research and development of novel therapeutic products, primarily for the treatment of Alzheimer’s disease. Vivoryon has identified a novel therapeutic concept related to disease initiation and progression. The development approach focusses on pyroglutamate-Abeta (pGlu-Abeta) as a therapeutic strategy to target Alzheimer’s disease.

bmp Ventures Team

Oliver Borrmann

Founded

1997

Invested

1997

Stage

Expansion

Industry

Life Sciences & eHealth

Status

Aktiv